Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue-A Case Report and Brief Literature Review

Can J Gastroenterol Hepatol. 2016:2016:4837270. doi: 10.1155/2016/4837270. Epub 2016 Apr 21.

Abstract

Collagenous sprue (CS) is a distinct clinicopathological disorder histologically defined by a thickened subepithelial band (Freeman, 2011). It is a rare condition which has been recently observed in a significant proportion of sprue-like enteropathy associated with olmesartan, a novel entity described by Rubio-Tapia et al. in 2012. CS is historically associated with a poor prognosis (Marthey et al., 2014). However, histological and clinical improvements have been described in most studies with concomitant usage of corticosteroids and/or gluten-free diet (Marthey et al., 2014). We report a unique case of olmesartan-induced collagenous sprue in a 79-year-old man that showed complete histological and clinical remission with the sole withdrawal of the incriminating drug. The literature on this topic is briefly reviewed.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antihypertensive Agents / adverse effects*
  • Collagenous Sprue / chemically induced*
  • Diarrhea / chemically induced
  • Humans
  • Hypertension / drug therapy
  • Imidazoles / adverse effects*
  • Male
  • Tetrazoles / adverse effects*
  • Withholding Treatment

Substances

  • Antihypertensive Agents
  • Imidazoles
  • Tetrazoles
  • olmesartan